Please login to the form below
EMIG
This page shows the latest EMIG news and features for those working in and with pharma, biotech and healthcare.
Still no ferry contracts for no-deal Brexit medicines supplies
EMIG, the UK industry group which represents a range of companies, including SMEs, has just announced results from its latest survey of members. ... 44% of EMIG Members surveyed who stockpiled medicines/medical devices prior to 29 March, have run down or
Latest news
-
Pharma’s confidence in Brexit deal falls as vote looms
Most EMIG members have little or no confidence in the government’s abilities to obtain a good deal. ... may be delayed or abandoned, although EMIG’s data doesn’t indicate why sentiment on disruption is improving.
-
New ‘voluntary’ UK pricing deal caps growth, but promises faster uptake
Others in the industry have voiced their support for the deal, including Novartis' UK country president Haseeb Ahmad and EMIG's chairman Leslie Galloway, who says the ABPI's negotiating team
-
Decision time for Brexit
Industry bodies, including the ABPI, BIA and EMIG wrote a joint letter to the health secretary Matt Hancock two weeks ago, requesting an 'urgent roundtable' on no deal medicines supply chain ... planning, but EMIG's chairman Leslie Galloway says the
-
Health secretary’s ‘rip off’ remarks anger UK pharma
Leslie Galloway, chairman of EMIG, the UK industry group for small-to-medium pharma companies says these factors are endangering the UK sector.
-
UK unveils plans for bigger medicines price squeeze
The UK industry organisations the ABPI and EMIG (the latter representing SMEs) are yet to comment on the statutory scheme proposals, which coincide with the hugely complex and uncertain Brexit plans,
More from news
Approximately 3 fully matching, plus 19 partially matching documents found.
Latest Intelligence
-
Setting up for success in a post-Brexit, post-pandemic Britain
Having said that, EMIG (Ethical Medicines Industry Group) has been with us every step of the way and I am extremely grateful for its counsel and support, as we establish a
-
Transforming clinical trial data into a long-term asset
Ethical Medicines Industry Group (EMIG) to commission a survey of life sciences professionals: Arkivum ‘TMF Futures: Keeping Data Alive’. ... About the report. The first Arkivum TMF Futures: Keeping Data Alive survey was conducted in July 2020 by
-
Evolution or revolution: the latest review of NICE methods
Those who gave evidence to the APPG included staff from the Cystic Fibrosis Trust, Takeda, AstraZeneca, EMIG and FIECON, as well as from NICE.
-
The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
By Leslie Galloway, chairman, Ethical Medicines Industry Group EMIG, whose 270 member companies supply 50% of branded medicines by volume in the UK.
-
The UK’s new five-year pricing agreement
Industry leaders who have voiced their support for the deal include Novartis’ UK country president Haseeb Ahmad and EMIG’s chairman Leslie Galloway, who says the ABPI’s negotiating team had
More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Ethical Medicines Industry Group
EMIG is the trade association in the UK that represents the interests of small to medium-sized pharmaceutical companies. ... EMIG member companies range from start-ups, whose prime focus is R&D, to highly developed businesses delivering essential
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- Sanofi halts recruitment for trials assessing MS treatment
- Eli Lilly to make bebtelovimab commercially available to US states from August
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Powering Rapid Cognitive Analysis with AI
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS and 2seventy bio announce positive results for multiple myeloma treatment
- Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
- Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
- JCVI publishes statement on London polio vaccination strategy
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris
- EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
PMHub
The Good Ideas Group
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...
